254 related articles for article (PubMed ID: 17683897)
21. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
Skene CD; Doidge C; Sutton P
Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
[TBL] [Abstract][Full Text] [Related]
22. The design of vaccines against Helicobacter pylori and their development.
Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori inflammation, immunity, and vaccines.
D'Elios MM; Andersen LP
Helicobacter; 2007 Oct; 12 Suppl 1():15-9. PubMed ID: 17727455
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
25. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism.
Lv X; Yang J; Song H; Li T; Guo L; Xing Y; Xi T
Vaccine; 2014 Sep; 32(41):5343-52. PubMed ID: 25093281
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
28. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
29. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice.
Nemattalab M; Shenagari M; Taheri M; Mahjoob M; Nazari Chamaki F; Mojtahedi A; Hasan-Alizadeh E; Ashrafkhani B; Mousavi Niri N
Cytokine; 2020 Feb; 126():154866. PubMed ID: 31629103
[TBL] [Abstract][Full Text] [Related]
32. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice.
Chen J; Lin M; Li N; Lin L; She F
Vaccine; 2012 Aug; 30(36):5310-5. PubMed ID: 22749593
[TBL] [Abstract][Full Text] [Related]
34. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
[TBL] [Abstract][Full Text] [Related]
35. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
Keenan JI; Rijpkema SG; Durrani Z; Roake JA
FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
[TBL] [Abstract][Full Text] [Related]
36. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
Harbour SN; Mitchell HM; Sutton P
Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
[TBL] [Abstract][Full Text] [Related]
37. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice.
Zhang M; Berndt BE; Eaton KA; Rathinavelu S; Pierzchala A; Kao JY
Helicobacter; 2008 Jun; 13(3):200-8. PubMed ID: 18466395
[TBL] [Abstract][Full Text] [Related]
39. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
[TBL] [Abstract][Full Text] [Related]
40. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
